Provectus Biopharmaceuticals (PVCT) Receivables - Net (2018 - 2024)
Provectus Biopharmaceuticals' Receivables - Net came in at $767.00 for Q2 2024, down 47.5% from $1,461 a year earlier but up 682.7% from the prior quarter.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Receivables - Net (2018 - 2024) Analysis & Trends
At the end of FY2023, Provectus Biopharmaceuticals' Receivables - Net was $476.00, up 20.8% from FY2022.
- Receivables - Net carries a five-year compound annual growth rate of -76.0% (FY2018 to FY2023).
- Going back by year, Receivables - Net was $394.00 in FY2022 (-92.3%), $5,107 in FY2021 (+29.9%), $3,930 in FY2020 (-92.9%) and $55,058 in FY2019 (-90.8%).
- The five-year range for quarterly Receivables - Net is $98.00 (Q1 2024) to $282,112 (Q3 2019).
- Year-over-year, Receivables - Net increased in two of the last eight quarters, with an average decline of 39.8%.
- The fastest year-over-year change in Receivables - Net over five years came in Q3 2023 (growth of 67.9%), and the weakest in Q2 2020 (a decline of 98.7%).
- Business Quant data shows PVCT's Receivables - Net at $98.00 (Q1 2024), $476.00 (Q4 2023) and $947.00 (Q3 2023) in the three quarters before Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 767.00 |
| Mar 31, 2024 | 98.00 |
| Dec 31, 2023 | 476.00 |
| Sep 30, 2023 | 947.00 |
| Jun 30, 2023 | 1,461.00 |
| Mar 31, 2023 | 767.00 |
| Dec 31, 2022 | 394.00 |
| Sep 30, 2022 | 564.00 |
| Jun 30, 2022 | 2,744.00 |
| Mar 31, 2022 | 3,050.00 |
| Dec 31, 2021 | 5,107.00 |
| Sep 30, 2021 | 1,354.00 |
| Jun 30, 2021 | 5,408.00 |
| Mar 31, 2021 | 4,388.00 |
| Dec 31, 2020 | 3,930.00 |
| Sep 30, 2020 | 5,930.00 |
| Jun 30, 2020 | 3,777.00 |
| Mar 31, 2020 | 74,235.00 |
| Dec 31, 2019 | 55,058.00 |
| Sep 30, 2019 | 282,112.00 |
API Access
Provectus Biopharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();